The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Death: The Significance of Apoptosis
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980) · International Review of Cytology · doi:10.1016/s0074-7696(08)62312-8 · Cited by 7,162
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Self-citationCooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.
Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., & Cotman, C. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7951 · Cited by 1,030
Westermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976
Neurotoxicity of a prion protein fragment
Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O., & Tagliavini, F. (1993) · Nature · doi:10.1038/362543a0 · Cited by 943
Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease
Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907
Self-citationIslet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.
Westermark, P., Engström, U., Johnson, K. H., Westermark, G. T., & Betsholtz, C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5036 · Cited by 807
New fluorescent dyes for lymphocyte migration studies
Weston, S. A., & Parish, C. R. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90322-m · Cited by 484
Leighton, B., & Cooper, G. J. S. (1988) · Nature · doi:10.1038/335632a0 · Cited by 473
Cited by
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Masters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Self-citationIslet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044
“The issue of protein toxicity entered the diabetes field in 1994, again through a study by the Yankner group (211), in which they showed that fibrils of human IAPP are toxic to adult human and rat islet cells in vitro.”
BackgroundNLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
Yankner, B. A. (1996) · Neuron · doi:10.1016/s0896-6273(00)80115-4 · Cited by 955
Self-citationIncreased Risk of Type 2 Diabetes in Alzheimer Disease
Janson, J., Laedtke, T., Parisi, J. E., O’Brien, P., Petersen, R. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.2.474 · Cited by 950
Soto, C., Sigurdsson, E. M., Morelli, L., Asok Kumar, R., Castaño, E. M., & Frangione, B. (1998) · Nature Medicine · doi:10.1038/nm0798-822 · Cited by 876
Cognitive Dysfunction and Diabetes Mellitus
Kodl, C. T., & Seaquist, E. R. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0034 · Cited by 802
Sakuraba, H., Mizukami, H., Yagihashi, N., Wada, R., Hanyu, C., & Yagihashi, S. (2002) · Diabetologia · doi:10.1007/s125-002-8248-z · Cited by 681
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes
Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 660
Endoplasmic Reticulum Stress and Type 2 Diabetes
Back, S. H., & Kaufman, R. J. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072909-095555 · Cited by 619
Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis
Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 612
Janson, J., Ashley, R. H., Harrison, D., McIntyre, S., & Butler, P. C. (1999) · Diabetes · doi:10.2337/diabetes.48.3.491 · Cited by 612
β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595
Self-citationIslet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes
Hull, R. L., Westermark, G. T., Westermark, P., & Kahn, S. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0405 · Cited by 583
Luca, S., Yau, W.-M., Leapman, R., & Tycko, R. (2007) · Biochemistry · doi:10.1021/bi701427q · Cited by 578
Islet Amyloid and Type 2 Diabetes Mellitus
Höppener, J. W. M., Ahrén, B., & Lips, C. J. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008103430607 · Cited by 521
VAN ROSSUM, D., HANISCH, U.-K., & QUIRION, R. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00023-1 · Cited by 516
Pathogenesis of Type 2 Diabetes Mellitus
Leahy, J. L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.003 · Cited by 469
Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane
Engel, M. F. M., Khemtémourian, L., Kleijer, C. C., Meeldijk, H. J. D., Jacobs, J., Verkleij, A. J., de Kruijff, B., Killian, J. A., & Höppener, J. W. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708354105 · Cited by 466
Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches
Behl, C. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00055-0 · Cited by 445
Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin
Mirzabekov, T. A., Lin, M.-C., & Kagan, B. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.4.1988 · Cited by 442
The toxicity in vitro of β-amyloid protein
Iversen, L. L., Mortishire-Smith, R. J., Pollack, S. J., & Shearman, M. S. (1995) · Biochemical Journal · doi:10.1042/bj3110001 · Cited by 429
Tenidis, K., Waldner, M., Bernhagen, J., Fischle, W., Bergmann, M., Weber, M., Merkle, M.-L., Voelter, W., Brunner, H., & Kapurniotu, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3422 · Cited by 426
Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide
Azriel, R., & Gazit, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102883200 · Cited by 420
Butler, A. E., Janson, J., Soeller, W. C., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2304 · Cited by 411
Ma, B., & Nussinov, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212206899 · Cited by 403
Amyloid peptides are toxic via a common oxidative mechanism.
Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., & Kimura, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.1989 · Cited by 379
A potential role for apoptosis in neurodegeneration and Alzheimer's disease
Cotman, C. W., & Anderson, A. J. (1995) · Molecular Neurobiology · doi:10.1007/bf02740836 · Cited by 378
Common pathological processes in Alzheimer disease and type 2 diabetes: A review
Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367
El-Agnaf, O. M. A., Jakes, R., Curran, M. D., Middleton, D., Ingenito, R., Bianchi, E., Pessi, A., Neill, D., & Wallace, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01418-5 · Cited by 363
Islet inflammation in type 2 diabetes and physiology
Eguchi, K., & Nagai, R. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88877 · Cited by 361
Phospholipid Catalysis of Diabetic Amyloid Assembly
Knight, J. D., & Miranker, A. D. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.086 · Cited by 357
Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in Vitro
Kayed, R., Bernhagen, J., Greenfield, N., Sweimeh, K., Brunner, H., Voelter, W., & Kapurniotu, A. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2646 · Cited by 351
Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide.
Janson, J., Soeller, W. C., Roche, P. C., Nelson, R. T., Torchia, A. J., Kreutter, D. K., & Butler, P. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7283 · Cited by 342
Böni-Schnetzler, M., Boller, S., Debray, S., Bouzakri, K., Meier, D. T., Prazak, R., Kerr-Conte, J., Pattou, F., Ehses, J. A., Schuit, F. C., et al. (2009) · Endocrinology · doi:10.1210/en.2009-0543 · Cited by 339
Implications of peptide assemblies in amyloid diseases
Ke, P. C., Sani, M.-A., Ding, F., Kakinen, A., Javed, I., Separovic, F., Davis, T. P., & Mezzenga, R. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00372b · Cited by 338
β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition
Jurgens, C. A., Toukatly, M. N., Fligner, C. L., Udayasankar, J., Subramanian, S. L., Zraika, S., Aston-Mourney, K., Carr, D. B., Westermark, P., Westermark, G. T., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.02.036 · Cited by 329
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.
Porte, D., & Kahn, S. E. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s160 · Cited by 332
Watching amyloid fibrils grow by time-lapse atomic force microscopy 1 1Edited by W. Baumeister
Goldsbury, C., Kistler, J., Aebi, U., Arvinte, T., & Cooper, G. J. S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2299 · Cited by 326
Amyloid Fibril Formation from Full-Length and Fragments of Amylin
Goldsbury, C., Goldie, K., Pellaud, J., Seelig, J., Frey, P., Müller, S. A., Kistler, J., Cooper, G. J. S., & Aebi, U. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4268 · Cited by 316
Hui, H., Nourparvar, A., Zhao, X., & Perfetti, R. (2003) · Endocrinology · doi:10.1210/en.2002-220897 · Cited by 307
Hormones and Disorders of Mineral Metabolism
Bringhurst, F. R., Demay, M. B., & Kronenberg, H. M. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00028-6 · Cited by 298
Islet β cell mass in diabetes and how it relates to function, birth, and death
Weir, G. C., & Bonner‐Weir, S. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12031 · Cited by 296
Self-citationKawahara, M., Kuroda, Y., Arispe, N., & Rojas, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14077 · Cited by 294
Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology
Jaikaran, E. T. A. S., & Clark, A. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00078-3 · Cited by 294
Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins
Munishkina, L. A., & Fink, A. L. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.03.015 · Cited by 294
Diagnosis, screening and management of cystic fibrosis related diabetes mellitus
Moran, A., Hardin, D., Rodman, D., Allen, H. F., Beall, R. J., Borowitz, D., Brunzell, C., Campbell III, P. W., Chesrown, S. E., Duchow, C., et al. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00058-3 · Cited by 293
Polymorphic Fibrillar Assembly of Human Amylin
Goldsbury, C. S., Cooper, G. J. S., Goldie, K. N., Müller, S. A., Saafi, E. L., Gruijters, W. T. M., Misur, M. P., Engel, A., Aebi, U., & Kistler, J. (1997) · Journal of Structural Biology · doi:10.1006/jsbi.1997.3858 · Cited by 293
Shim, S.-H., Gupta, R., Ling, Y. L., Strasfeld, D. B., Raleigh, D. P., & Zanni, M. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805957106 · Cited by 286
Verchere, C. B., D'Alessio, D. A., Palmiter, R. D., Weir, G. C., Bonner-Weir, S., Baskin, D. G., & Kahn, S. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3492 · Cited by 278
Self-citationMeng, F., Abedini, A., Plesner, A., Verchere, C. B., & Raleigh, D. P. (2010) · Biochemistry · doi:10.1021/bi100939a · Cited by 282
Hoorens, A., Van de Casteele, M., Klöppel, G., & Pipeleers, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118950 · Cited by 277
Butler, A. E., Jang, J., Gurlo, T., Carty, M. D., Soeller, W. C., & Butler, P. C. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1509 · Cited by 267
Lorenzo, A., Yuan, M., Zhang, Z., Paganetti, P. A., Sturchler-Pierrat, C., Staufenbiel, M., Mautino, J., Vigo, F. S., Sommer, B., & Yankner, B. A. (2000) · Nature Neuroscience · doi:10.1038/74833 · Cited by 258
Self-citationUlloa‐Aguirre, A., Janovick, J. A., Brothers, S. P., & Conn, P. M. (2004) · Traffic · doi:10.1111/j.1600-0854.2004.00232.x · Cited by 253
Misra, R. N., Xiao, H.-Y., Kim, K. S., Lu, S., Han, W.-C., Barbosa, S. A., Hunt, J. T., Rawlins, D. B., Shan, W., Ahmed, S. Z., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0305568 · Cited by 252
Is Alzheimer’s disease a systemic disease?
Morris, J. K., Honea, R. A., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.012 · Cited by 219
The aggregation potential of human amylin determines its cytotoxicity towards islet β‐cells
Konarkowska, B., Aitken, J. F., Kistler, J., Zhang, S., & Cooper, G. J. S. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05367.x · Cited by 219
Qiao, Q., Bowman, G. R., & Huang, X. (2013) · Journal of the American Chemical Society · doi:10.1021/ja403147m · Cited by 182
Human IAPP–induced pancreatic β cell toxicity and its regulation by autophagy
Shigihara, N., Fukunaka, A., Hara, A., Komiya, K., Honda, A., Uchida, T., Abe, H., Toyofuku, Y., Tamaki, M., Ogihara, T., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69866 · Cited by 177
Höppener, J. W. M., Oosterwijk, C., Nieuwenhuis, M. G., Posthuma, G., Thijssen, J. H. H., Vroom, T. M., Ahrén, B., & Lips, C. J. M. (1999) · Diabetologia · doi:10.1007/s001250051175 · Cited by 153
Endoplasmic Reticulum Stress and Diabetes Mellitus.
ARAKI, E., OYADOMARI, S., & MORI, M. (2003) · Internal Medicine · doi:10.2169/internalmedicine.42.7 · Cited by 151
Islet Amyloid Polypeptide (IAPP) Transgenic Rodents as Models for Type 2 Diabetes
Matveyenko, A. V., & Butler, P. C. (2006) · ILAR Journal · doi:10.1093/ilar.47.3.225 · Cited by 150
“In support, human IAPP (but not rodent IAPP) induces apoptosis when added to cells in culture (Janson et al. 1999; Lorenzo et al. 1994; Ritzel and Butler 2003).”
BackgroundIslet amyloid polypeptide toxicity and membrane interactions
Cao, P., Abedini, A., Wang, H., Tu, L.-H., Zhang, X., Schmidt, A. M., & Raleigh, D. P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305517110 · Cited by 146
Replication Increases β-Cell Vulnerability to Human Islet Amyloid Polypeptide-Induced Apoptosis
Ritzel, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1701 · Cited by 115
Impaired islet turnover in human donor pancreata with aging
Reers, C., Erbel, S., Esposito, I., Schmied, B., Büchler, M. W., Nawroth, P. P., & Ritzel, R. A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0596 · Cited by 113
Metabolic stress, IAPP and islet amyloid
Montane, J., Klimek‐Abercrombie, A., Potter, K. J., Westwell‐Roper, C., & Bruce Verchere, C. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01657.x · Cited by 98
Wang, F., Hull, R. L., Vidal, J., Cnop, M., & Kahn, S. E. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2514 · Cited by 77
β‐cell mass in people with type 2 diabetes
Cho, J., Kim, J., Shin, J., Shin, J., & Yoon, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00072.x · Cited by 69
Islets in type 2 diabetes: in honor of Dr. Robert C. Turner
Bonner-Weir, S., & O'Brien, T. D. (2008) · Diabetes · doi:10.2337/db07-1842 · Cited by 66
“While mature amyloid fibrils were initially thought to be the likely mediators of hIAPP toxicity, it has become increasingly apparent that it is actually the relatively small soluble oligomers of hIAPP that are most toxic to -cells (26,33).”
BackgroundLutz, T. A. (2022) · Appetite · doi:10.1016/j.appet.2022.105965 · Cited by 59
Adeghate, E., & Kalász, H. (2011) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104501105010078 · Cited by 51
Metadata
- Authors
- Lorenzo, A., Razzaboni, B., Weir, G. C., & Yankner, B. A.
- Venue
- Nature
- Published
- 1994-04
- Volume
- 368
- Issue
- 6473
- Pages
- 756-760
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1964172387
- Cited by
- 820
- References
- 30
- FWCI
- 29.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.